UGCG and ovarian carcinoma: A GC-rich/Sp1 promoter binding region in important in the regulation of GCS expression; furthermore, doxorubicin can induce the activation of Sp1 and the upregulation of GCS and apoptosis in the leukemia drug-resistant cell line HL-60/ADR in addition to an ovarian cancer cell line [8].